Comments*

 
  • Events 

    Thursday, April 16, 2015 | 8:00 AM - 7:00 PM

    Nutrition and the Science of Disease Prevention: A Systems Approach to Support Metabolic Health

    Keynote Speaker: Frank Hu (Harvard School of Public Health)
    Speakers: Brian Bennett (University of North Carolina), Kevin Hall (National Institutes of Health), Rudolph Leibel (Columbia University), Patricia Mabry (National Institutes of Health), Anne McCartney (University of Reading), Christina A. Roberto (Harvard T.H. Chan School of Public Health)

    This one-day conference will highlight the connection between nutrition and the complex science of preventing disease. Speakers will focus on promotion of optimal metabolic health, building on input from several complementary disciplines.

    Tuesday, May 26, 2015 | 8:30 AM - 4:30 PM

    Quantitative Systems Pharmacology: Progress Towards Integration into Drug Discovery and Development

    Speakers: Richard Allen (Pfizer), John Burke (Applied BioMath), Nitin Mehrotra (US Food and Drug Administration), Tim Rolph (Pfizer), Vikram Sinha (US Food and Drug Administration), Peter Sorger (Harvard Medical School), Paul Watkins (Hamner-UNC Institute for Drug Safety Sciences)

    Quantitative Systems Pharmacology (QSP) has been used successfully in drug discovery and development, yet lacks industry-wide adoption. This symposium highlights past successes and future challenges of using QSP in preclinical and clinical research.

    Friday, June 19, 2015 | 8:00 AM - 7:00 PM

    Microbes in the City: Mapping the Urban Genome

    Efforts to map all of the genetic information of microbial communities that make up the urban genome—from kiosks and subways, to soil and sewage—seek to improve the health and productivity of the built environments in which we live.

    Tuesday, October 27, 2015 | 8:30 AM - 5:00 PM

    Phenotypic and Biomarker-Based Drug Discovery

    Speakers: Andras Bauer (Boehringer Ingelheim), Alex Huang (Genentech), Bryan Laffitte (Genomics Institute of the Novartis Research Foundation), Jonathan Lee (Eli Lilly ), Lorenz Mayr (AstraZeneca), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Robert Temple (US Food and Drug Administration )

    This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.

  • Past Events

    Wednesday, January 21, 2015 | 8:30 AM - 4:00 PM

    The New York Structural Biology Discussion Group 10th Winter Meeting

    Speakers: Jasna Brujic (New York University), Bridget Carragher, John Chodera, Oliver Clarke, Erik Debler, Nancy Greenbaum, David Hall, Barry Honig, Jinrang Kim (Columbia University), Nina Liu (Albert Einstein College of Medicine), Patrick Loria (Yale University), Sean McSweeney (Brookhaven National Lab), Clint Potter

    The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.

    Monday, November 3, 2014 | 8:00 AM - 4:30 PM

    Gene Network Changes in Alzheimer's Disease: Potential Points for Therapeutic Intervention

    Speakers: Kwame O. Affram (Uniformed Services University), Erik H.W.G.M. Boddeke (University Medical Center Groningen), Oleg Butovsky (Brigham and Women's Hospital and Harvard Medical School), Philip L. De Jager (Harvard University and Brigham and Women's Hospital), Joseph El Khoury (Massachusetts General Hospital and Harvard Medical School), Miriam Merad (Icahn School of Medicine at Mount Sinai), Michael C. Oldham (University of California, San Francisco), Vishal Sahni (Eisai Inc), Bin Zhang (Icahn School of Medicine at Mount Sinai)

    Next generation sequencing of Alzheimer’s disease (AD) progression reveals gene networks within microglial pathways. This symposium focuses on microglia biology, molecular signatures specific to microglial phenotypes, and phenotype modulation.

    Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM

    Chemical Biology Discussion Group Year-End Symposium

    Keynote Speaker: Michael Marletta (The Scripps Research Institute)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.

    Friday, March 28, 2014 | 9:00 AM - 5:00 PM

    8th Annual Machine Learning Symposium

    Keynote Speakers: Rayid Ghani (University of Chicago), Brian Kingsbury (IBM), Jorge Nocedal (Northwestern University)

    Chief Data Scientist for the 'Obama for America' 2012 re-election campaign, and other experts, explore the latest innovations in harnessing the power of big data through machine learning.

  • Publications 

    Annals

    Competitive Visual Processing Across Space and Time: Attention, Memory, and Prediction

    Edited by Werner X. Schneider (Bielefeld University), Wolfgang Einhäuser (Bielefeld University and Philipps-University Marburg), and Gernot Horstmann (Bielefeld University)

    This Annals volume explores three memory-related aspects of competitive visual processing: interactions of attention and working memory, attention and long-term memory, and attention and prediction.

    Volume 1339

    eBriefing

    Systems Biology Approaches to Secondary Metabolites and Metabonomics

    Organizers: Manuel X. Duval (Boehringer Ingelheim Pharmaceuticals; University of New Haven), Thomas B. Freeman (Boehringer Ingelheim Pharmaceuticals), and Jennifer Henry (The New York Academy of Sciences)
    Speakers: Sean F. Brady (The Rockefeller University), Steven Edgar (Massachusetts Institute of Technology), Justin Nodwell (University of Toronto, Canada), and Kang Zhou (Massachusetts Institute of Technology)

    This eBriefing explores a systems biology approach to secondary metabolites and their networks, looking at their biological effects and potential benefits for human health.

    eBriefing

    Venomics: Drug Discovery from Nature's Deadliest

    Organizers: Mandë Holford (Hunter College, CUNY; American Museum of Natural History), Steven Gross (Weill Cornell Medical College), and Jennifer Henry (The New York Academy of Sciences)
    Keynote Speaker: Baldomero M. Olivera (University of Utah)

    Venomous animals, including spiders, snakes, scorpions, sea snails, leeches, and others, produce millions of bioactive compounds, offering enormous potential for venom-based drug discovery.

    eBriefing

    Preclinical Drug–Drug Interaction: Risk Assessment and Toxicity

    Organizers: Myrtle Davis (National Cancer Institute, NIH), Raymond A. Kemper (Merck), Marla Weetall (PTC Therapeutics), and Jennifer Henry (The New York Academy of Sciences)

    This eBriefing explores approaches to predict potential drug–drug interactions before clinical trials in humans.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.